May 15: Budget Impact Analysis I: A 6-Step Approach - In Person at ISPOR 2022
1:00PM-5:00PM Eastern Daylight Time (EDT)
This course will describe the methods used to estimate the budget impact of a new health care technology and will present six basic steps for estimating budget impact: (1) estimating the target population; (2) selecting a time horizon; (3) identifying current and projected treatment mix; (4) estimating current and future drug costs; (5) estimating change in disease-related costs; and (6) estimating and presenting changes in annual budget impact and health outcomes. Both static and dynamic methods for estimating the budget and health impact of adding a new drug to a health plan formulary will be presented. These six steps will be illustrated using actual budget impact models. This course is designed for those with some experience with pharmacoeconomic analysis.
***Registrants will receive a digital course book. Copyright, Trademark and Confidentiality Policies apply.***
University of Maryland, School of Pharmacy
Baltimore, MD, USA
Stephanie R. Earnshaw, PhD, MS
RTI Health Solutions
Research Triangle Park, NC, USA
Ashley E. Davis, PhD, MSc
Director, Health Economics
RTI Health Solutions
Research Triangle Park, NC, USA
![event-Short-Courses event-Short-Courses](https://www.ispor.org/images/default-source/default-album/event-short-courses.png?sfvrsn=934c5e55_6)
May 15, 2022
Back to all short courses
Budget Impact Analysis I: A 6-Step Approach
LEVEL: Introductory
TRACK: Economic Evaluation
LENGTH: 4 Hours | Course runs 1 day
This short course will be offered in-person at the ISPOR 2022 conference. Separate registration is required. Visit the ISPOR 2022 website to register and learn more.
1:00PM-5:00PM Eastern Daylight Time (EDT)
DESCRIPTION
This course will describe the methods used to estimate the budget impact of a new health care technology and will present six basic steps for estimating budget impact: (1) estimating the target population; (2) selecting a time horizon; (3) identifying current and projected treatment mix; (4) estimating current and future drug costs; (5) estimating change in disease-related costs; and (6) estimating and presenting changes in annual budget impact and health outcomes. Both static and dynamic methods for estimating the budget and health impact of adding a new drug to a health plan formulary will be presented. These six steps will be illustrated using actual budget impact models. This course is designed for those with some experience with pharmacoeconomic analysis. ***Registrants will receive a digital course book. Copyright, Trademark and Confidentiality Policies apply.***
FACULTY MEMBERS
C. Daniel Mullins, PhDUniversity of Maryland, School of Pharmacy
Baltimore, MD, USA
Stephanie R. Earnshaw, PhD, MS
RTI Health Solutions
Research Triangle Park, NC, USA
Ashley E. Davis, PhD, MSc
Director, Health Economics
RTI Health Solutions
Research Triangle Park, NC, USA
Basic Schedule:
4 Hours | Course runs 1 Day